Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

NCT02666430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Mylan's insulin glargine
DRUG: Lantus®

Sponsor

Mylan Inc.

Collaborators

[object Object]